BioSpace News Archive

Ceapro Inc.(TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced operational highlights and financial results for the fourth quarter and full year ended December 31, 2019.

Company earns top marks from both sponsors and investigative sites for service; continues to support customers with innovative and remote approaches during unprecedented time

Masks headed to healthcare facilities have incorporated Sciessent’s Agion® antimicrobial technology.

Vayyar collaborates with Israel’s Ministry of Defense to utilize a touchless remote monitoring system that detects and monitors vital signs that can indicate early-stage COVID-19 symptoms

Accelerated Enrollment Solutions (AES), a business of PPD, Inc. (Nasdaq:PPD), has launched a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites from other research facilities impacted by the coronavirus crisis.

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its proprietary VivaGel® active, astodrimer sodium (SPL7013), has been shown in laboratory studies to have significant antiviral activity against the coronavirus that causes COVID-19 (coronavirus disease).

HCA Healthcare, one of the nation’s leading healthcare providers, announced it will provide as many as 1,000 ventilators as part of the American Hospital Association’s collaboration with the federal government and health systems to distribute this critical piece of equipment to hospitals experiencing a surge of patients with COVID-19.

Getinge introduces one of its latest connectivity solutions for acute care products.

The global gynecological devices market is marked by a high degree of fragmentation due to the presence of several large and small manufacturers, reports Transparency Market Research in a new business intelligence study.

The demand within the global constipation treatment market is growing at a sturdy pace in recent times.